Cargando…
The effect of age on the response to the pneumococcal polysaccharide vaccine
BACKGROUND: Streptococcus pneumoniae is a leading cause of morbidity and mortality in the elderly. To prevent invasive pneumococcal diseases, the 23-valent pneumococcal polysaccharide vaccine (PPV) is recommended in subjects over 65 years of age. Although it has been reported to provide approximatel...
Autores principales: | Lee, Hyunju, Nahm, Moon H, Kim, Kyung-Hyo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856571/ https://www.ncbi.nlm.nih.gov/pubmed/20219110 http://dx.doi.org/10.1186/1471-2334-10-60 |
Ejemplares similares
-
The 7-valent pneumococcal conjugate vaccine elicits cross-functional opsonophagocytic killing responses to Streptococcus pneumoniae serotype 6D in children
por: Lee, Hyunju, et al.
Publicado: (2013) -
Nasopharyngeal Pneumococcal Carriage of Children Attending Day Care Centers in Korea: Comparison between Children Immunized with 7-valent Pneumococcal Conjugate Vaccine and Non-immunized
por: Kim, Kyung-Hyo, et al.
Publicado: (2011) -
Indirect Effects of Pneumococcal Conjugate Vaccines in National Immunization Programs for Children on Adult Pneumococcal Disease
por: Kim, Young Keun, et al.
Publicado: (2016) -
Towards New Broader Spectrum Pneumococcal Vaccines: The Future of Pneumococcal Disease Prevention
por: Lee, Lucia H., et al.
Publicado: (2014) -
Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination
por: van den Biggelaar, Anita H. J., et al.
Publicado: (2017)